tirzepatide phase 3 Efficacy of in 2 (GPGB; [14]) and phase (SURPASS-1 The SURMOUNT-MAINTAIN Phase 3b trial

Tesofensine offers an advantage in terms of compliance, as it reduces appetite cravings and helps maintain calorie control

Side effects included nausea (39% of patients), diarrhea (25%) and vomiting (28%) [29] Overall, orfoglipron achieves comparable weight loss with other GLP1R agonists such as semaglutide and Rybelsus, but has a slightly better side effect profile and achieves weight loss in a shorter period of time

You have prediabetes with modest weight goals: If your goal is primarily metabolic improvement (better blood sugar) with incidental modest weight loss, metformin may suffice

Met de juiste voedingskeuzes krijgen lichaam en brein de brandstof die ze nodig hebben om optimaal te functioneren.